Exploiting a Bacterial Nano-Syringe for Protein Therapeutics
利用细菌纳米注射器进行蛋白质治疗
基本信息
- 批准号:7515332
- 负责人:
- 金额:$ 33.62万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-08-01 至 2011-07-31
- 项目状态:已结题
- 来源:
- 关键词:AmazeApoptoticBacterial ProteinsCellsDevelopmentDevicesDiseaseElementsEngineeringEnzymesGenesGenetic TranscriptionGoalsHumanInheritedInjection of therapeutic agentLearningMolecularMolecular MachinesMutateNanotechnologyPathologyPeptidesProteinsRangeSyringesSystemTherapeuticToxinTumor Suppressor ProteinsWorkdesigndesireinhibitor/antagonistmicrobialnanonanomachinepathogenic bacteriapolypeptidetherapeutic proteintool
项目摘要
DESCRIPTION (provided by applicant): The great promise of nanotechnology is the development of "molecular machines" for a myriad of uses, and especially within biomedicine. Extensive efforts are underway to design and produce such machines from a variety of elements and first principles. We propose to take a "reverse-engineering" approach to this problem by exploiting a molecular machine that has evolved within the microbial world, a bacterial protein injection system called the "molecular syringe." This device has evolved in pathogenic bacteria to precisely deliver protein toxins into human cells, and therefore functions as a "nano-syringe," converting energy into the work of protein injection. We plan to use this injection device to deliver into diseased cells functional versions of eukaryotic proteins that have been mutated or otherwise rendered non-functional in the illness, as well as proteins and peptides that may inhibit the action of malfunctioning proteins. Examples include restoring functional tumor suppressors or pro-apoptotic polypeptides into transformed lines, injecting enzymes mutated in inherited diseases, and adding inhibitors of transcription to achieve a desired shut down in certain genes whose expression leads to pathology. Should these goals be realized, we will have learned to harness an amazing bacterial nano-machine for biomedical applications, providing a new and powerful tool for treating a potentially broad range of diseases.
Project Narrative: We propose to adapt a bacterial protein injection system to precisely deliver protein and peptide therapeutics into diseased human cells Examples include restoring functional tumor suppressors or pro-apoptotic polypeptides into transformed lines, injecting enzymes mutated in inherited diseases, and adding inhibitors of transcription to achieve a desired shut down in certain genes whose expression leads to pathology. Should these goals be realized, we will have learned to harness this amazing bacterial nano- machine for biomedical applications, providing a new and powerful tool for treating a potentially broad range of diseases.
描述(由申请人提供):纳米技术的巨大前景是开发用于无数用途的“分子机器”,特别是在生物医学中。正在进行广泛的努力,从各种元素和第一原理设计和生产这样的机器。我们建议采取一种“逆向工程”的方法来解决这个问题,利用一种在微生物世界中进化的分子机器,一种被称为“分子注射器”的细菌蛋白质注射系统。这种装置在致病菌中进化,可以精确地将蛋白质毒素输送到人体细胞中,因此可以作为“纳米注射器”,将能量转化为蛋白质注射的工作。我们计划使用这种注射装置向患病细胞中输送功能性真核蛋白质,这些蛋白质在疾病中已经突变或以其他方式变得无功能,以及可能抑制功能障碍蛋白质作用的蛋白质和肽。实例包括将功能性肿瘤抑制因子或促凋亡多肽恢复到转化的细胞系中,注射在遗传性疾病中突变的酶,以及添加转录抑制剂以实现其表达导致病理的某些基因的期望关闭。如果这些目标得以实现,我们将学会利用一种惊人的细菌纳米机器用于生物医学应用,为治疗潜在的广泛疾病提供一种新的强大工具。
项目叙述:我们提出调整细菌蛋白质注射系统以精确地将蛋白质和肽治疗剂递送到患病的人类细胞中。实例包括将功能性肿瘤抑制剂或促凋亡多肽恢复到转化的细胞系中,注射在遗传性疾病中突变的酶,以及添加转录抑制剂以实现其表达导致病理的某些基因中的期望关闭。如果这些目标得以实现,我们将学会利用这种惊人的细菌纳米机器进行生物医学应用,为治疗潜在的广泛疾病提供一种新的强大工具。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Charles Erec Stebbins其他文献
Charles Erec Stebbins的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Charles Erec Stebbins', 18)}}的其他基金
Interactions of Helicobacter pylori CagA with Host Factors
幽门螺杆菌 CagA 与宿主因子的相互作用
- 批准号:
8352946 - 财政年份:2012
- 资助金额:
$ 33.62万 - 项目类别:
Assembly and Function of the Bacterial Type III Secretion System Basal Body
细菌III型分泌系统基体的组装和功能
- 批准号:
8535920 - 财政年份:2012
- 资助金额:
$ 33.62万 - 项目类别:
Interactions of Helicobacter pylori CagA with Host Factors
幽门螺杆菌 CagA 与宿主因子的相互作用
- 批准号:
8503595 - 财政年份:2012
- 资助金额:
$ 33.62万 - 项目类别:
H PYLORI CAGA INHIBITS PAR1-MARK FAMILY KINASES BY MIMICKING HOST SUBSTRATES
H PYLORI CAGA 通过模仿宿主底物抑制 PAR1 标记家族激酶
- 批准号:
8361570 - 财政年份:2011
- 资助金额:
$ 33.62万 - 项目类别:
STRUCTURAL CHARACTERIZATION OF THE TYPE 3 SECRETION SYSTEM
3 型分泌系统的结构特征
- 批准号:
8361578 - 财政年份:2011
- 资助金额:
$ 33.62万 - 项目类别:
H PYLORI CAGA INHIBITS PAR1-MARK FAMILY KINASES BY MIMICKING HOST SUBSTRATES
H PYLORI CAGA 通过模仿宿主底物抑制 PAR1 标记家族激酶
- 批准号:
8169199 - 财政年份:2010
- 资助金额:
$ 33.62万 - 项目类别:
Exploiting a Bacterial Nano-Syringe for Protein Therapeutics
利用细菌纳米注射器进行蛋白质治疗
- 批准号:
7886773 - 财政年份:2008
- 资助金额:
$ 33.62万 - 项目类别:
Exploiting a Bacterial Nano-Syringe for Protein Therapeutics
利用细菌纳米注射器进行蛋白质治疗
- 批准号:
7656802 - 财政年份:2008
- 资助金额:
$ 33.62万 - 项目类别:
Structural Studies of Bacterial Virulence Factors
细菌毒力因子的结构研究
- 批准号:
7656998 - 财政年份:2002
- 资助金额:
$ 33.62万 - 项目类别:
Structural Studies of Bacterial Virulence Factors
细菌毒力因子的结构研究
- 批准号:
7363517 - 财政年份:2002
- 资助金额:
$ 33.62万 - 项目类别:
相似海外基金
Mechanisms that underlie the life/death decisions in a cell that activated apoptotic caspases
细胞中激活凋亡半胱天冬酶的生/死决策的机制
- 批准号:
10607815 - 财政年份:2023
- 资助金额:
$ 33.62万 - 项目类别:
Nuclear and chromatin aberrations during non-apoptotic cell death in C. elegans and mammals
线虫和哺乳动物非凋亡细胞死亡过程中的核和染色质畸变
- 批准号:
10723868 - 财政年份:2023
- 资助金额:
$ 33.62万 - 项目类别:
Non-apoptotic functions of caspase-3 in neural development
Caspase-3在神经发育中的非凋亡功能
- 批准号:
10862033 - 财政年份:2023
- 资助金额:
$ 33.62万 - 项目类别:
Apoptotic Donor Leukocytes to Promote Kidney Transplant Tolerance
凋亡供体白细胞促进肾移植耐受
- 批准号:
10622209 - 财政年份:2023
- 资助金额:
$ 33.62万 - 项目类别:
Design of apoptotic cell mimetic anti-inflammatory polymers for the treatment of cytokine storm
用于治疗细胞因子风暴的模拟凋亡细胞抗炎聚合物的设计
- 批准号:
22H03963 - 财政年份:2022
- 资助金额:
$ 33.62万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Identifying the mechanisms behind non-apoptotic functions of mitochondrial matrix-localized MCL-1
确定线粒体基质定位的 MCL-1 非凋亡功能背后的机制
- 批准号:
10537709 - 财政年份:2022
- 资助金额:
$ 33.62万 - 项目类别:
Environmental Carcinogens Induce Minority MOMP to Initiate Carcinogenesis in Lung Cancer and Mesothelioma whileMaintaining Apoptotic Resistance via Mcl-1
环境致癌物诱导少数 MOMP 引发肺癌和间皮瘤的癌变,同时通过 Mcl-1 维持细胞凋亡抵抗
- 批准号:
10356565 - 财政年份:2022
- 资助金额:
$ 33.62万 - 项目类别:
Targeting apoptotic cells to enhance radiotherapy
靶向凋亡细胞以增强放射治疗
- 批准号:
10708827 - 财政年份:2022
- 资助金额:
$ 33.62万 - 项目类别:
Activation of non-apoptotic cell death by the DNA damage response
DNA 损伤反应激活非凋亡细胞死亡
- 批准号:
10388929 - 财政年份:2022
- 资助金额:
$ 33.62万 - 项目类别:
Role of natural immunity to self apoptotic exosomes in maintaining immune homeostasis
对自凋亡外泌体的自然免疫在维持免疫稳态中的作用
- 批准号:
RGPIN-2021-03004 - 财政年份:2022
- 资助金额:
$ 33.62万 - 项目类别:
Discovery Grants Program - Individual














{{item.name}}会员




